Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

ClinicoEconomics and Outcomes Research


Archive: Volume 13, 2021

A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia

Derseh MT, Solomon K, Tamene W, Beneberu W, Yayehrad AT, Ambaye AS

ClinicoEconomics and Outcomes Research 2021, 13:821-834

Published Date: 16 September 2021

Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction

Grabner M, Burchard J, Nguyen C, Chung H, Gangan N, Boniface JJ, Zupancic JAF, Stanek E

ClinicoEconomics and Outcomes Research 2021, 13:809-820

Published Date: 14 September 2021

Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States

Shah A, Tosh JC, Ambavane A, Nikolaou A, Hogea C, Samyshkin Y, Gorsh B, Maiese EM, Wang F

ClinicoEconomics and Outcomes Research 2021, 13:789-800

Published Date: 10 September 2021

Obesity, Disability and Self-Perceived Health Outcomes in Australian Adults: A Longitudinal Analysis Using 14 Annual Waves of the HILDA Cohort

Keramat SA, Alam K, Ahinkorah BO, Islam MS, Islam MI, Hossain MZ, Ahmed S, Gow J, Biddle SJ

ClinicoEconomics and Outcomes Research 2021, 13:777-788

Published Date: 7 September 2021

Mask Mandates and COVID-19 Related Symptoms in the US

Nguyen M

ClinicoEconomics and Outcomes Research 2021, 13:757-766

Published Date: 16 August 2021

The Economic Implications of Introducing Single-Patient ECG Systems for Cardiac Surgery in Australia

Saunders R, Hansson Hedblom A

ClinicoEconomics and Outcomes Research 2021, 13:727-735

Published Date: 13 August 2021

Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome

Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U

ClinicoEconomics and Outcomes Research 2021, 13:703-715

Published Date: 29 July 2021

Patient Flows, Patient Distribution Computations and Medicines Accounting in the Pharmacoeconomic Models Through Procurement Perspective

Yagudina R, Kulikov A, Serpik V, Borodin A, Vygodchikova I

ClinicoEconomics and Outcomes Research 2021, 13:673-680

Published Date: 23 July 2021

Patient-Reported Outcomes for Migraine in the US and Europe: Burden Associated with Multiple Preventive Treatment Failures

Ford J, Nichols RM, Ye W, Tockhorn-Heidenreich A, Cotton S, Jackson J

ClinicoEconomics and Outcomes Research 2021, 13:647-660

Published Date: 14 July 2021

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]

Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

ClinicoEconomics and Outcomes Research 2021, 13:645-646

Published Date: 14 July 2021

Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy

Perrone V, Sangiorgi D, Andretta M, Ducci G, Forti B, Francesa Morel PC, Gambera M, Maina G, Mencacci C, Mennini FS, Zanalda E, Degli Esposti L

ClinicoEconomics and Outcomes Research 2021, 13:629-635

Published Date: 5 July 2021

Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana

Ofei-Palm CNK, Tagoe NN, Jatoe D, Agyare A, Ankrah D

ClinicoEconomics and Outcomes Research 2021, 13:619-627

Published Date: 2 July 2021

Patient Characteristics and Risk Factors in Invasive Mold Infections: Comparison from a Systematic Review and Database Analysis

Sung AH, Martin S, Phan B, Benigno M, Stephens J, Chambers R, Aram JA

ClinicoEconomics and Outcomes Research 2021, 13:593-602

Published Date: 25 June 2021

Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis

Santos-Moreno P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, de la Hoz-Restrepo F, Alvis-Guzmán N

ClinicoEconomics and Outcomes Research 2021, 13:583-591

Published Date: 23 June 2021

Helmet Wearing Saves the Cost of Motorcycle Head Injuries: A Case Study from Karachi, Pakistan

Ali A, Malik MA, Khan UR, Khudadad U, Raheem A, Hyder AA

ClinicoEconomics and Outcomes Research 2021, 13:573-581

Published Date: 23 June 2021

The Burden of X-Linked Retinitis Pigmentosa on Patients and Society: A Narrative Literature Review

Chivers M, Li N, Pan F, Wieffer H, Slowik R, Leartsakulpanitch J

ClinicoEconomics and Outcomes Research 2021, 13:565-572

Published Date: 23 June 2021

Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK

Aksan A, Beales ILP, Baxter G, Ramirez de Arellano A, Gavata S, Valentine WJ, Hunt B

ClinicoEconomics and Outcomes Research 2021, 13:541-552

Published Date: 17 June 2021

Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis

Santos-Moreno P, Alvis-Zakzuk NJ, Castillo E, Villarreal L, Pineda C, Sandoval H, Valencia O

ClinicoEconomics and Outcomes Research 2021, 13:519-529

Published Date: 16 June 2021

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus

Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F, Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM

ClinicoEconomics and Outcomes Research 2021, 13:503-518

Published Date: 14 June 2021

Lifestyle Risk Factor Assessment Through WHO STEP Approach in Tabriz, Iran

Golestani M, Sadeghi-Bazargani H, Saadati M, Farahbakhsh M, Dalal K

ClinicoEconomics and Outcomes Research 2021, 13:487-492

Published Date: 10 June 2021

Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation

Ferrario L, Schettini F, Avogaro A, Bellia C, Bertuzzi F, Bonetti G, Ceriello A, Ciaccio M, Corsi Romanelli M, Dozio E, Falqui L, Girelli A, Nicolucci A, Perseghin G, Plebani M, Valentini U, Zaninotto M, Castaldi S, Foglia E

ClinicoEconomics and Outcomes Research 2021, 13:453-464

Published Date: 27 May 2021

Comparative Cost and Effectiveness of a New Algorithm for Early Lyme Disease Diagnosis: Evaluation in US, Germany, and Italy

Pradelli L, Pinciroli M, Houshmand H, Grassi B, Bonelli F, Calleri M, Ruscio M

ClinicoEconomics and Outcomes Research 2021, 13:437-451

Published Date: 26 May 2021

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls

Bedenbaugh AV, Bonafede M, Marchlewicz EH, Lee V, Tambiah J

ClinicoEconomics and Outcomes Research 2021, 13:421-435

Published Date: 21 May 2021

Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial

Chirikov VV, Walker C, Stephens JM, Schepman P, Chambers R, Bakir M, Poorman GW, Haider S, Farghaly M

ClinicoEconomics and Outcomes Research 2021, 13:409-420

Published Date: 19 May 2021

Change and Innovation in Healthcare: Findings from Literature

Milella F, Minelli EA, Strozzi F, Croce D

ClinicoEconomics and Outcomes Research 2021, 13:395-408

Published Date: 19 May 2021

Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis

Bindra J, Chopra I, Niewoehner J, Panaccio M, Wan GJ

ClinicoEconomics and Outcomes Research 2021, 13:349-358

Published Date: 6 May 2021

Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review

Rodriguez-Sanchez B, Aranda-Reneo I, Oliva-Moreno J, Lopez-Bastida J

ClinicoEconomics and Outcomes Research 2021, 13:307-334

Published Date: 29 April 2021

Ultrasound-Guided Pudendal Nerve Block in Patients Undergoing Open Hemorrhoidectomy: A Post-Hoc Cost-Effectiveness Analysis from a Double-Blind Randomized Controlled Trial

Mongelli F, Lucchelli M, La Regina D, Christoforidis D, Saporito A, Vannelli A, Di Giuseppe M

ClinicoEconomics and Outcomes Research 2021, 13:299-306

Published Date: 28 April 2021

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

ClinicoEconomics and Outcomes Research 2021, 13:263-277

Published Date: 22 April 2021

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan

Tokunaga K, Suzuki C, Hasegawa M, Fujimori I

ClinicoEconomics and Outcomes Research 2021, 13:241-250

Published Date: 16 April 2021

Factors and Economic Outcomes Associated with Documented Difficult Intubation in the United States

Moucharite MA, Zhang J, Giffin R

ClinicoEconomics and Outcomes Research 2021, 13:227-239

Published Date: 1 April 2021

Costs of Biopsy and Complications in Patients with Lung Cancer

Chiu YW, Kao YH, Simoff MJ, Ost DE, Wagner O, Lavin J, Culbertson RA, Smith DG

ClinicoEconomics and Outcomes Research 2021, 13:191-200

Published Date: 17 March 2021

Cost-Utility Analysis of Anterior Vertebral Body Tethering versus Spinal Fusion in Idiopathic Scoliosis from a US Integrated Healthcare Delivery System Perspective

Polly DW, Larson AN, Samdani AF, Rawlinson W, Brechka H, Porteous A, Marsh W, Ditto R

ClinicoEconomics and Outcomes Research 2021, 13:175-190

Published Date: 15 March 2021

Willingness to Pay for Childhood Malaria Vaccine Among Caregivers of Under-Five Children in Northwest Ethiopia

Wagnew Y, Hagos T, Weldegerima B, Debie A

ClinicoEconomics and Outcomes Research 2021, 13:165-174

Published Date: 15 March 2021

The Trend of Direct Medical Cost of Meliodiosis Patients in Kedah: A Retrospective Study from 2014 to 2017

Mardhiah K, Wan-Arfah N, Naing NN, Abu Hassan MR, Chan HK, Hasan H

ClinicoEconomics and Outcomes Research 2021, 13:155-162

Published Date: 11 March 2021

Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database

Matsumoto T, Tsuchiya T, Hirano T, Laurent T, Matsunaga K, Takata J

ClinicoEconomics and Outcomes Research 2021, 13:145-153

Published Date: 25 February 2021

New Perspective to Improve Care of Patients with Infected Diabetic Foot Ulcer: Early Economic Impact of the Use of Photodynamic Therapy with RLP068 (Based) System

Lorenzoni V, Chiavetta A, Curci V, Della Pepa G, Licciardello C, Pantò F, Scatena A, Turchetti G

ClinicoEconomics and Outcomes Research 2021, 13:135-144

Published Date: 26 February 2021

Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective

Stevens M, Davis T, Munson SH, Shenoy AV, Gricar BLA, Yapici HO, Shaw AD

ClinicoEconomics and Outcomes Research 2021, 13:109-119

Published Date: 5 February 2021

Catastrophic Health Expenditure among Chronic Patients Attending Dessie Referral Hospital, Northeast Ethiopia

Shumet Y, Mohammed SA, Kahissay MH, Demeke B

ClinicoEconomics and Outcomes Research 2021, 13:99-107

Published Date: 3 February 2021

Inequality and Inequity in Outpatient Care Utilization in Ethiopia: A Decomposition Analysis of Ethiopian National Health Accounts

Kifle H, Merga BT, Dessie Y, Demena M, Fekadu G, Negash B

ClinicoEconomics and Outcomes Research 2021, 13:89-98

Published Date: 2 February 2021

Budget Impact Associated with the Introduction of the Impella 5.0® Mechanical Circulatory Support Device for Cardiogenic Shock in France

Le Guyader A, Pernot M, Delmas C, Roze S, Fau I, Flecher E, Lebreton G

ClinicoEconomics and Outcomes Research 2021, 13:53-63

Published Date: 19 January 2021